Keryx Biopharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.06.18	Akebia Therapeutics, Keryx Biopharma To Merge - Quick Facts (RTTNews)
01.05.18	INGN Soars On Revised Outlook, MRK Faces FDA In Sep., KPTI Taken By STORM (RTTNews)
04.12.17	ShoulderHill Events Partners with The Climate Reality Project for the 7th annual "24 Hours of Reality" (PR Newswire)
08.11.17	FDA Nod For COLL, INGN Ups View, Positive News Dimmed By Earnings Miss At KERX (RTTNews)
07.11.17	Keryx: FDA OKs Auryxia Tablets For Iron Deficiency Anemia With CKD (RTTNews)
07.11.17	FDA Lifts Hold On CLLS' Trials, Double Delight For Roche, COLL Will Have To Wait (RTTNews)
27.10.17	Biotech Stocks Facing FDA Decision In November (RTTNews)
06.09.17	Technical Reports on Biotech Equities -- Celgene, Dynavax Technologies, Keryx Biopharma, and Moleculin Biotech (PR Newswire)
02.08.17	Breakfast Technical Briefing on Biotech Stocks -- Dynavax Technologies, Keryx Biopharma, La Jolla Pharma, and Moleculin Biotech (PR Newswire)
29.06.17	Louisiana Solicitor General Liz Murrill Joins Tony Perkins on the Radio to Discuss the Lawsuit Against Louisiana's Abortion Clinic Standards (PR Newswire)
22.06.17	Breakfast Technical Briefing on Biotech Stocks -- CytRx, Keryx Biopharma, TG Therapeutics, and ZIOPHARM Oncology (PR Newswire)
20.04.17	Biotech Stocks Under Scanner -- Biostage, Keryx Biopharma, Kite Pharma, and ZIOPHARM Oncology (PR Newswire)
02.03.17	Technical Reports on Biotech Stocks -- Halozyme Therapeutics, CytRx, Cara Therapeutics, and Keryx Biopharma (PR Newswire)
12.01.17	Technical Reports on Biotech Stocks -- Halozyme Therapeutics, Keryx Biopharma, Curis, and Agios Pharma (PR Newswire)
01.12.16	Biotech Stocks Under Scanner -- Geron, Keryx Biopharma, Heat Biologics, and ZIOPHARM Oncology (PR Newswire)
29.03.16	Keryx Jumps On Positive Late-Stage Trial Results (RTTNews)
24.09.15	Keryx Receives European Approval for Fexeric(R) (ferric citrate coordination complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease (GlobeNewswire)
27.07.15	Keryx Biopharma Appoints Scott Holmes As CFO (RTTNews)
12.01.15	Keryx Biopharma To Change CEO Role From Ron Bentsur To Greg Madison (RTTNews)
22.12.14	Keryx Biopharma Announces Commercial Launch Of AURYXIA Tablets In The U.S. (RTTNews)
04.12.14	Keryx Biopharma Announces Patent For Auryxia - Quick Facts (RTTNews)
29.09.14	Keryx Biopharma Begins Phase 3 Trial Of Ferric Citrate - Quick Facts (RTTNews)
08.09.14	ACT Gets Its Act Right, HART Given Privileged Status, FDA Nod Fails To Lift KERX (RTTNews)
05.09.14	Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia (GlobeNewswire)
23.05.14	EDAP Confirms FDA Panel Date, ISIS Reports Data, RedHill Touches New Peak (RTTNews)
12.03.14	Keryx Biopharma Q4 Loss Widens - Quick Facts (RTTNews)
11.03.14	La Jolla Shines, ETRM Gets New Decision Date, NWBO Going North, RGDO Explodes (RTTNews)
10.02.14	Keryx Biopharma Names Greg Madison EVP And COO (RTTNews)
08.11.13	Keryx Biopharma Reports Preliminary Data From Safety Extension Study Of Zerenex (RTTNews)
06.11.13	MYGN, SGEN Boost Outlook, AMRI On A High, ENDP Opens Wallet, IMGN Slammed (RTTNews)
05.11.13	Keryx Posts Wider Net Loss In Q3, But Shares Up (RTTNews)
05.11.13	ACUR To Meet With FDA, CYTX Does A Deal, NNVC Renews Contract, RGLS On Watch (RTTNews)
05.11.13	Keryx Biopharma Q3 Loss Widens (RTTNews)
22.10.13	Oxygen Bio Breathes Anew, KERX Gets FDA Date, Rockwell Continues To Rock (RTTNews)
18.10.13	Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx (PR Newswire)
17.10.13	Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. (PR Newswire)
17.10.13	Critical Alerts For Goldman Sachs, Netflix, Nasdaq, Aetna, and Keryx Biopharmaceuticals Released By InvestorsObserver (PR Newswire)
09.10.13	Beating The Street (RTTNews)
09.10.13	Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company (PR Newswire)
08.10.13	Keryx Says FDA Accepts For Filing Of Zerenex New Drug Application (RTTNews)
26.09.13	Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo (PR Newswire)
19.09.13	Technical Scrutiny: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. (PR Newswire)
29.08.13	M&A Activities, Pending NDA Approvals, and Clinical Trial Results - Research Report on Sanofi, GSK, AstraZeneca, Keryx, and Rigel (PR Newswire)
14.08.13	Before the Bell Scans: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. (PR Newswire)
08.08.13	Keryx Biopharmaceuticals Announces New Drug Application Submission for Zerenex™ for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis (PR Newswire)
01.08.13	Anika On A Roll, AEZS Makes That First Step, KERX To Watch Out For, STAAR Shines (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Keryx Biopharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten